Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Immuneering (IMRX) over the last 4 years, with Dec 2024 value amounting to $81,212.

  • Immuneering's Amortizatization of Intangibles fell 79.88% to $81,212 in Q4 2024 from the same period last year, while for Dec 2024 it was $257,485, marking a year-over-year decrease of 57.46%. This contributed to the annual value of $328,377 for FY2024, which is 67.73% down from last year.
  • Latest data reveals that Immuneering reported Amortizatization of Intangibles of $81,212 as of Q4 2024, which was up 1,009.91% from $7,317 recorded in Q3 2024.
  • Immuneering's Amortizatization of Intangibles' 5-year high stood at $403,631 during Q4 2023, with a 5-year trough of -$206,162 in Q4 2021.
  • In the last 3 years, Immuneering's Amortizatization of Intangibles had a median value of $44,264 in 2022 and averaged $93,939.
  • Per our database at Business Quant, Immuneering's Amortizatization of Intangibles slumped by 932.64% in 2021 and then surged by 478.66% in 2022.
  • Over the past 5 years, Immuneering's Amortizatization of Intangibles (Quarterly) stood at $24,760 in 2020, then slumped by 932.64% to -$206,162 in 2021, then surged by 150.98% to $105,097 in 2022, then skyrocketed by 284.06% to $403,631 in 2023, then crashed by 79.88% to $81,212 in 2024.
  • Its Amortizatization of Intangibles stands at $81,212 for Q4 2024, versus $7,317 for Q3 2024 and $7,317 for Q2 2024.